Industry Research Reports
Home > Reports > Electronics & Semiconductor > Global Microarray Biochips Market Outlook, In‑Depth Analysis & Forecast to 2031
Global Microarray Biochips Market Outlook, In‑Depth Analysis & Forecast to 2031
Industry: Electronics & Semiconductor
Published Date: 2025-08-08
Pages: 135 Pages
Report ld: 4920586
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Microarray Biochips Market Size(US$)
CAGR 2025-2031
8.9%
Market Size,2031
USD 2,550
Million
Market Snapshot
Market Size in 2025 (Value)
US$ 1,529 million
Market Forecast in 2031(Value)
US$ 2,550 million
CAGR
8.9%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Microarray Biochips market is projected to grow from US$ 1416 million in 2024 to US$ 2550 million by 2031, at a CAGR of 8.9% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Microarray or biochip is a lab-oriented microscope slide that is usually made of glass, silicon chip, or nylon membrane. It is a 2D array (sometimes 3D) whose surface is provided with thousands of minute pores in defined positions. The microarray is a recently developed technology and was discovered only two decades ago. It is mostly used in cancer research and in the pharmacological treatment of other diseases like oral lesions. It enables researchers to investigate and analyze the expression of thousands of genes in a single reaction and address various issues.
Illumina and Thermo Fisher Scientific are the two largest companies in the industry, accounting for more than 74 percent of 2018 revenue combined. In terms of production value, the United States occupies the absolute position, with production value accounting for more than 86%.
Report Includes:
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Microarray Biochips market, seamlessly integrating production capacity and sales performance across the value chain. It analyzes historical production, revenue, and sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—capacity, sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
By Company
- Illumina
- Thermo Fisher Scientific
- Agilent Technologies
- Bio-Rad Laboratories
- PerkinElmer
- BioChain
- Sengenics
- Applied Microarrays
- US Biomax
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- DNA Microarray
- Protein Microarray
- Other
Segment by Application
- Drug Discovery
- Research
- Diagnostics
- Others
CHAPTER OUTLINE
Chapter 1: Defines the Microarray Biochips study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Maps global production capacity, utilization, and market share (2020–2031), identifies efficient hubs, reveals regulatory/trade policy impacts and bottlenecks.
Chapter 4: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 5: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 6: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 7: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 8: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 9: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 10: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 11: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 12: Profiles manufacturers in depth—details product specs, capacity, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 13: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint and technology, cost drivers, plus downstream channels and distributor roles.
Chapter 14: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 7–11) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 13) and customers (Chapter 6) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 4 and 12).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 13 and 14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to Microarray Biochips: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Microarray Biochips Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 DNA Microarray
1.2.3 Protein Microarray
1.2.4 Other
1.3 Market Segmentation by Application
1.3.1 Global Microarray Biochips Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Drug Discovery
1.3.3 Research
1.3.4 Diagnostics
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Microarray Biochips Revenue Estimates and Forecasts 2020-2031
2.2 Global Microarray Biochips Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Microarray Biochips Sales Estimates and Forecasts 2020-2031
2.4 Global Microarray Biochips Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Global Production Analysis
3.1 Global Microarray Biochips Production Capacity and Utilization Rates (2020–2031)
3.2 Regional Production: Comparative Analysis (2020 VS 2024 VS 2031)
3.3 Regional Production Dynamics
3.3.1 Historic Production by Region (2020-2025)
3.3.2 Forecasted Production by Region (2026-2031)
3.3.3 Production Market Share by Region (2020-2031)
3.3.4 Regulatory and Trade Policy Impact on Production
3.3.5 Production Capacity Enablers and Constraints
3.4 Key Regional Production Hubs
3.4.1 North America
3.4.2 Southeast Asia
4 Competition by Manufacturers
4.1 Global Microarray Biochips Sales by Manufacturers
4.1.1 Global Sales Volume by Manufacturers (2020-2025)
4.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
4.2 Global Microarray Biochips Manufacturer Revenue Rankings and Tiers
4.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
4.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
4.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
4.3 Manufacturer Profitability Profiles and Pricing Strategies
4.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
4.3.2 Manufacturer-Level Price Trends (2020-2025)
4.4 Key Manufacturers Manufacturing Base and Headquarters
4.5 Main Product Type Market Size by Manufacturers
4.5.1 DNA Microarray Market Size by Manufacturers
4.5.2 Protein Microarray Market Size by Manufacturers
4.5.3 Other Market Size by Manufacturers
4.6 Global Microarray Biochips Market Concentration and Dynamics
4.6.1 Global Market Concentration (CR5 and HHI)
4.6.2 Entrant/Exit Impact Analysis
4.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
5 Global Product Segmentation Analysis
5.1 Global Microarray Biochips Sales Performance by Type
5.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
5.1.2 Global Sales Market Share by Type (2020-2031)
5.2 Global Microarray Biochips Revenue Trends by Type
5.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
5.2.2 Global Revenue Market Share by Type (2020-2031)
5.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
5.4 Product Technology Differentiation
5.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
5.5.1 High-Growth Niches and Adoption Drivers
5.5.2 Profitability Hotspots and Cost Drivers
5.5.3 Substitution Threats
6 Global Downstream Application Analysis
6.1 Global Microarray Biochips Sales by Application
6.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
6.1.2 Global Sales Market Share by Application (2020-2031)
6.1.3 High-Growth Application Identification
6.1.4 Emerging Application Case Studies
6.2 Global Microarray Biochips Revenue by Application
6.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
6.2.2 Revenue Market Share by Application (2020-2031)
6.3 Global Pricing Dynamics by Application (2020-2031)
6.4 Downstream Customer Analysis
6.4.1 Top Customers by Region
6.4.2 Top Customers by Application
7 North America
7.1 North America Sales Volume and Revenue (2020-2031)
7.2 North America Key Manufacturers Sales Revenue in 2024
7.3 North America Microarray Biochips Sales and Revenue by Type (2020-2031)
7.4 North America Microarray Biochips Sales and Revenue by Application (2020-2031)
7.5 North America Growth Accelerators and Market Barriers
7.6 North America Microarray Biochips Market Size by Country
7.6.1 North America Revenue by Country
7.6.2 North America Sales Trends by Country
7.6.3 US
7.6.4 Canada
7.6.5 Mexico
8 Europe
8.1 Europe Sales Volume and Revenue (2020-2031)
8.2 Europe Key Manufacturers Sales Revenue in 2024
8.3 Europe Microarray Biochips Sales and Revenue by Type (2020-2031)
8.4 Europe Microarray Biochips Sales and Revenue by Application (2020-2031)
8.5 Europe Growth Accelerators and Market Barriers
8.6 Europe Microarray Biochips Market Size by Country
8.6.1 Europe Revenue by Country
8.6.2 Europe Sales Trends by Country
8.6.3 Germany
8.6.4 France
8.6.5 U.K.
8.6.6 Italy
8.6.7 Russia
9 Asia-Pacific
9.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
9.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
9.3 Asia-Pacific Microarray Biochips Sales and Revenue by Type (2020-2031)
9.4 Asia-Pacific Microarray Biochips Sales and Revenue by Application (2020-2031)
9.5 Asia-Pacific Microarray Biochips Market Size by Region
9.5.1 Asia-Pacific Revenue by Region
9.5.2 Asia-Pacific Sales Trends by Region
9.6 Asia-Pacific Growth Accelerators and Market Barriers
9.7 Southeast Asia
9.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
9.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand
9.8 China
9.9 Japan
9.10 South Korea
9.11 China Taiwan
9.12 India
10 Central and South America
10.1 Central and South America Sales Volume and Revenue (2020-2031)
10.2 Central and South America Key Manufacturers Sales Revenue in 2024
10.3 Central and South America Microarray Biochips Sales and Revenue by Type (2020-2031)
10.4 Central and South America Microarray Biochips Sales and Revenue by Application (2020-2031)
10.5 Central and South America Investment Opportunities and Key Challenges
10.6 Central and South America Microarray Biochips Market Size by Country
10.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 Brazil
10.6.3 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
11.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
11.3 Middle East and Africa Microarray Biochips Sales and Revenue by Type (2020-2031)
11.4 Middle East and Africa Microarray Biochips Sales and Revenue by Application (2020-2031)
11.5 Middle East and Africa Investment Opportunities and Key Challenges
11.6 Middle East and Africa Microarray Biochips Market Size by Country
11.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
11.6.2 GCC Countries
11.6.3 Turkey
11.6.4 Egypt
11.6.5 South Africa
12 Corporate Profile
12.1 Illumina
12.1.1 Illumina Corporation Information
12.1.2 Illumina Business Overview
12.1.3 Illumina Microarray Biochips Product Models, Descriptions and Specifications
12.1.4 Illumina Microarray Biochips Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.1.5 Illumina Microarray Biochips Sales by Product in 2024
12.1.6 Illumina Microarray Biochips Sales by Application in 2024
12.1.7 Illumina Microarray Biochips Sales by Geographic Area in 2024
12.1.8 Illumina Microarray Biochips SWOT Analysis
12.1.9 Illumina Recent Developments
12.2 Thermo Fisher Scientific
12.2.1 Thermo Fisher Scientific Corporation Information
12.2.2 Thermo Fisher Scientific Business Overview
12.2.3 Thermo Fisher Scientific Microarray Biochips Product Models, Descriptions and Specifications
12.2.4 Thermo Fisher Scientific Microarray Biochips Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.2.5 Thermo Fisher Scientific Microarray Biochips Sales by Product in 2024
12.2.6 Thermo Fisher Scientific Microarray Biochips Sales by Application in 2024
12.2.7 Thermo Fisher Scientific Microarray Biochips Sales by Geographic Area in 2024
12.2.8 Thermo Fisher Scientific Microarray Biochips SWOT Analysis
12.2.9 Thermo Fisher Scientific Recent Developments
12.3 Agilent Technologies
12.3.1 Agilent Technologies Corporation Information
12.3.2 Agilent Technologies Business Overview
12.3.3 Agilent Technologies Microarray Biochips Product Models, Descriptions and Specifications
12.3.4 Agilent Technologies Microarray Biochips Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.3.5 Agilent Technologies Microarray Biochips Sales by Product in 2024
12.3.6 Agilent Technologies Microarray Biochips Sales by Application in 2024
12.3.7 Agilent Technologies Microarray Biochips Sales by Geographic Area in 2024
12.3.8 Agilent Technologies Microarray Biochips SWOT Analysis
12.3.9 Agilent Technologies Recent Developments
12.4 Bio-Rad Laboratories
12.4.1 Bio-Rad Laboratories Corporation Information
12.4.2 Bio-Rad Laboratories Business Overview
12.4.3 Bio-Rad Laboratories Microarray Biochips Product Models, Descriptions and Specifications
12.4.4 Bio-Rad Laboratories Microarray Biochips Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.4.5 Bio-Rad Laboratories Microarray Biochips Sales by Product in 2024
12.4.6 Bio-Rad Laboratories Microarray Biochips Sales by Application in 2024
12.4.7 Bio-Rad Laboratories Microarray Biochips Sales by Geographic Area in 2024
12.4.8 Bio-Rad Laboratories Microarray Biochips SWOT Analysis
12.4.9 Bio-Rad Laboratories Recent Developments
12.5 PerkinElmer
12.5.1 PerkinElmer Corporation Information
12.5.2 PerkinElmer Business Overview
12.5.3 PerkinElmer Microarray Biochips Product Models, Descriptions and Specifications
12.5.4 PerkinElmer Microarray Biochips Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.5.5 PerkinElmer Microarray Biochips Sales by Product in 2024
12.5.6 PerkinElmer Microarray Biochips Sales by Application in 2024
12.5.7 PerkinElmer Microarray Biochips Sales by Geographic Area in 2024
12.5.8 PerkinElmer Microarray Biochips SWOT Analysis
12.5.9 PerkinElmer Recent Developments
12.6 BioChain
12.6.1 BioChain Corporation Information
12.6.2 BioChain Business Overview
12.6.3 BioChain Microarray Biochips Product Models, Descriptions and Specifications
12.6.4 BioChain Microarray Biochips Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.6.5 BioChain Recent Developments
12.7 Sengenics
12.7.1 Sengenics Corporation Information
12.7.2 Sengenics Business Overview
12.7.3 Sengenics Microarray Biochips Product Models, Descriptions and Specifications
12.7.4 Sengenics Microarray Biochips Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.7.5 Sengenics Recent Developments
12.8 Applied Microarrays
12.8.1 Applied Microarrays Corporation Information
12.8.2 Applied Microarrays Business Overview
12.8.3 Applied Microarrays Microarray Biochips Product Models, Descriptions and Specifications
12.8.4 Applied Microarrays Microarray Biochips Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.8.5 Applied Microarrays Recent Developments
12.9 US Biomax
12.9.1 US Biomax Corporation Information
12.9.2 US Biomax Business Overview
12.9.3 US Biomax Microarray Biochips Product Models, Descriptions and Specifications
12.9.4 US Biomax Microarray Biochips Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.9.5 US Biomax Recent Developments
13 Value Chain and Supply-Chain Analysis
13.1 Microarray Biochips Industry Chain
13.2 Microarray Biochips Upstream Materials Analysis
13.2.1 Raw Materials
13.2.2 Key Suppliers Market Share & Risk Assessment
13.3 Microarray Biochips Integrated Production Analysis
13.3.1 Manufacturing Footprint Analysis
13.3.2 Production Technology Overview
13.3.3 Regional Cost Drivers
13.4 Microarray Biochips Sales Channels and Distribution Networks
13.4.1 Sales Channels
13.4.2 Distributors
14 Microarray Biochips Market Dynamics
14.1 Industry Trends and Evolution
14.2 Market Growth Drivers and Emerging Opportunities
14.3 Market Challenges, Risks, and Restraints
15 Key Findings in the Global Microarray Biochips Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.1.1 Research Programs/Design
16.1.1.2 Market Size Estimation
16.1.1.3 Market Breakdown and Data Triangulation
16.1.2 Data Source
16.1.2.1 Secondary Sources
16.1.2.2 Primary Sources
16.2 Author Details
TABLE OF FIGURES
List of Tables
Table 1. Global Microarray Biochips Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Microarray Biochips Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Microarray Biochips Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Microarray Biochips Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Microarray Biochips Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Microarray Biochips Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
Table 7. Global Microarray Biochips Sales by Region (2020-2025) & (K Units)
Table 8. Global Microarray Biochips Sales by Region (2026-2031) & (K Units)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Microarray Biochips Production Growth Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
Table 11. Global Microarray Biochips Production by Region (2020-2025) & (K Units)
Table 12. Global Microarray Biochips Production by Region (2026-2031) & (K Units)
Table 13. Global Microarray Biochips Sales by Manufacturers (2020-2025) & (K Units)
Table 14. Global Microarray Biochips Sales Share by Manufacturers (2020-2025)
Table 15. Global Microarray Biochips Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 16. Global Microarray Biochips Revenue Market Share by Manufacturers (2020-2025)
Table 17. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 18. Global Microarray Biochips by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Microarray Biochips as of 2024)
Table 19. Global Microarray Biochips Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 20. Global Microarray Biochips Average Selling Price (ASP) by Manufacturers (2020-2025) & (USD/Unit)
Table 21. Key Manufacturers Microarray Biochips Manufacturing Base and Headquarters
Table 22. Global Microarray Biochips Market Concentration Ratio (CR5 and HHI)
Table 23. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 24. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 25. Global Microarray Biochips Sales by Type (2020-2025) & (K Units)
Table 26. Global Microarray Biochips Sales by Type (2026-2031) & (K Units)
Table 27. Global Microarray Biochips Revenue by Type (2020-2025) & (US$ Million)
Table 28. Global Microarray Biochips Revenue by Type (2026-2031) & (US$ Million)
Table 29. Global Microarray Biochips ASP by Type (2020-2031) & (USD/Unit)
Table 30. Technical Specifications by Key Product Type
Table 31. Global Microarray Biochips Sales by Application (2020-2025) & (K Units)
Table 32. Global Microarray Biochips Sales by Application (2026-2031) & (K Units)
Table 33. Microarray Biochips High-Growth Sectors Demand CAGR (2024-2031)
Table 34. Global Microarray Biochips Revenue by Application (2020-2025) & (US$ Million)
Table 35. Global Microarray Biochips Revenue by Application (2026-2031) & (US$ Million)
Table 36. Global Microarray Biochips ASP by Application (2020-2031) & (USD/Unit)
Table 37. Top Customers by Region
Table 38. Top Customers by Application
Table 39. North America Microarray Biochips Growth Accelerators and Market Barriers
Table 40. North America Microarray Biochips Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 41. North America Microarray Biochips Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 42. Europe Microarray Biochips Growth Accelerators and Market Barriers
Table 43. Europe Microarray Biochips Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 44. Europe Microarray Biochips Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 45. Asia-Pacific Microarray Biochips Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Asia-Pacific Microarray Biochips Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 47. Asia-Pacific Microarray Biochips Growth Accelerators and Market Barriers
Table 48. Southeast Asia Microarray Biochips Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 49. Central and South America Microarray Biochips Investment Opportunities and Key Challenges
Table 50. Central and South America Microarray Biochips Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 51. Middle East and Africa Microarray Biochips Investment Opportunities and Key Challenges
Table 52. Middle East and Africa Microarray Biochips Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 53. Illumina Corporation Information
Table 54. Illumina Description and Major Businesses
Table 55. Illumina Product Models, Descriptions and Specifications
Table 56. Illumina Capacity, Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 57. Illumina Sales Value Proportion by Product in 2024
Table 58. Illumina Sales Value Proportion by Application in 2024
Table 59. Illumina Sales Value Proportion by Geographic Area in 2024
Table 60. Illumina Microarray Biochips SWOT Analysis
Table 61. Illumina Recent Developments
Table 62. Thermo Fisher Scientific Corporation Information
Table 63. Thermo Fisher Scientific Description and Major Businesses
Table 64. Thermo Fisher Scientific Product Models, Descriptions and Specifications
Table 65. Thermo Fisher Scientific Capacity, Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 66. Thermo Fisher Scientific Sales Value Proportion by Product in 2024
Table 67. Thermo Fisher Scientific Sales Value Proportion by Application in 2024
Table 68. Thermo Fisher Scientific Sales Value Proportion by Geographic Area in 2024
Table 69. Thermo Fisher Scientific Microarray Biochips SWOT Analysis
Table 70. Thermo Fisher Scientific Recent Developments
Table 71. Agilent Technologies Corporation Information
Table 72. Agilent Technologies Description and Major Businesses
Table 73. Agilent Technologies Product Models, Descriptions and Specifications
Table 74. Agilent Technologies Capacity, Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 75. Agilent Technologies Sales Value Proportion by Product in 2024
Table 76. Agilent Technologies Sales Value Proportion by Application in 2024
Table 77. Agilent Technologies Sales Value Proportion by Geographic Area in 2024
Table 78. Agilent Technologies Microarray Biochips SWOT Analysis
Table 79. Agilent Technologies Recent Developments
Table 80. Bio-Rad Laboratories Corporation Information
Table 81. Bio-Rad Laboratories Description and Major Businesses
Table 82. Bio-Rad Laboratories Product Models, Descriptions and Specifications
Table 83. Bio-Rad Laboratories Capacity, Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 84. Bio-Rad Laboratories Sales Value Proportion by Product in 2024
Table 85. Bio-Rad Laboratories Sales Value Proportion by Application in 2024
Table 86. Bio-Rad Laboratories Sales Value Proportion by Geographic Area in 2024
Table 87. Bio-Rad Laboratories Microarray Biochips SWOT Analysis
Table 88. Bio-Rad Laboratories Recent Developments
Table 89. PerkinElmer Corporation Information
Table 90. PerkinElmer Description and Major Businesses
Table 91. PerkinElmer Product Models, Descriptions and Specifications
Table 92. PerkinElmer Capacity, Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. PerkinElmer Sales Value Proportion by Product in 2024
Table 94. PerkinElmer Sales Value Proportion by Application in 2024
Table 95. PerkinElmer Sales Value Proportion by Geographic Area in 2024
Table 96. PerkinElmer Microarray Biochips SWOT Analysis
Table 97. PerkinElmer Recent Developments
Table 98. BioChain Corporation Information
Table 99. BioChain Description and Major Businesses
Table 100. BioChain Product Models, Descriptions and Specifications
Table 101. BioChain Capacity, Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 102. BioChain Recent Developments
Table 103. Sengenics Corporation Information
Table 104. Sengenics Description and Major Businesses
Table 105. Sengenics Product Models, Descriptions and Specifications
Table 106. Sengenics Capacity, Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 107. Sengenics Recent Developments
Table 108. Applied Microarrays Corporation Information
Table 109. Applied Microarrays Description and Major Businesses
Table 110. Applied Microarrays Product Models, Descriptions and Specifications
Table 111. Applied Microarrays Capacity, Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 112. Applied Microarrays Recent Developments
Table 113. US Biomax Corporation Information
Table 114. US Biomax Description and Major Businesses
Table 115. US Biomax Product Models, Descriptions and Specifications
Table 116. US Biomax Capacity, Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 117. US Biomax Recent Developments
Table 118. Key Raw Materials Distribution
Table 119. Raw Materials Key Suppliers
Table 120. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 121. Milestones in Production Technology Evolution
Table 122. Distributors List
Table 123. Market Trends and Market Evolution
Table 124. Market Drivers and Opportunities
Table 125. Market Challenges, Risks, and Restraints
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
List of Figures
Figure 1. Microarray Biochips Product Picture
Figure 2. Global Microarray Biochips Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. DNA Microarray Product Picture
Figure 4. Protein Microarray Product Picture
Figure 5. Other Product Picture
Figure 6. Global Microarray Biochips Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 7. Drug Discovery
Figure 8. Research
Figure 9. Diagnostics
Figure 10. Others
Figure 11. Microarray Biochips Report Years Considered
Figure 12. Global Microarray Biochips Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Microarray Biochips Revenue (2020-2031) & (US$ Million)
Figure 14. Global Microarray Biochips Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 15. Global Microarray Biochips Revenue Market Share by Region (2020-2031)
Figure 16. Global Microarray Biochips Sales (2020-2031) & (K Units)
Figure 17. Global Microarray Biochips Sales (CAGR) by Region (2020-2031) (K Units)
Figure 18. Global Microarray Biochips Sales Market Share by Region (2020-2031)
Figure 19. Global Microarray Biochips Capacity, Production and Utilization (2020-2031) & (K Units)
Figure 20. Global Microarray Biochips Production Trend by Region (2020-2031) (K Units)
Figure 21. Global Microarray Biochips Production Market Share by Region (2020-2031)
Figure 22. Production Capacity Enablers & Constraints
Figure 23. Microarray Biochips Production Growth Rate in North America (2020-2031) & (K Units)
Figure 24. Microarray Biochips Production Growth Rate in Southeast Asia (2020-2031) & (K Units)
Figure 25. Top 5 and Top 10 Manufacturers Microarray Biochips Sales Volume Market Share in 2024
Figure 26. Global Microarray Biochips Revenue Market Share Ranking (2024)
Figure 27. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 28. DNA Microarray Revenue Market Share by Manufacturer in 2024
Figure 29. Protein Microarray Revenue Market Share by Manufacturer in 2024
Figure 30. Other Revenue Market Share by Manufacturer in 2024
Figure 31. Type Eight Revenue Market Share by Manufacturer in 2024
Figure 32. Type Nine Revenue Market Share by Manufacturer in 2024
Figure 33. Global Microarray Biochips Sales Market Share by Type (2020-2031)
Figure 34. Global Microarray Biochips Revenue Market Share by Type (2020-2031)
Figure 35. Global Microarray Biochips Sales Market Share by Application (2020-2031)
Figure 36. Global Microarray Biochips Revenue Market Share by Application (2020-2031)
Figure 37. North America Microarray Biochips Sales YoY (2020-2031) & (K Units)
Figure 38. North America Microarray Biochips Revenue YoY (2020-2031) & (US$ Million)
Figure 39. North America Top 5 Manufacturers Microarray Biochips Sales Revenue (US$ Million) in 2024
Figure 40. North America Microarray Biochips Sales Volume (K Units) by Type (2020- 2031)
Figure 41. North America Microarray Biochips Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 42. North America Microarray Biochips Sales Volume (K Units) by Application (2020-2031)
Figure 43. North America Microarray Biochips Sales Revenue (US$ Million) by Application (2020-2031)
Figure 44. US Microarray Biochips Revenue (2020-2031) & (US$ Million)
Figure 45. Canada Microarray Biochips Revenue (2020-2031) & (US$ Million)
Figure 46. Mexico Microarray Biochips Revenue (2020-2031) & (US$ Million)
Figure 47. Europe Microarray Biochips Sales YoY (2020-2031) & (K Units)
Figure 48. Europe Microarray Biochips Revenue YoY (2020-2031) & (US$ Million)
Figure 49. Europe Top 5 Manufacturers Microarray Biochips Sales Revenue (US$ Million) in 2024
Figure 50. Europe Microarray Biochips Sales Volume (K Units) by Type (2020-2031)
Figure 51. Europe Microarray Biochips Sales Revenue (US$ Million) by Type (2020-2031)
Figure 52. Europe Microarray Biochips Sales Volume (K Units) by Application (2020-2031)
Figure 53. Europe Microarray Biochips Sales Revenue (US$ Million) by Application (2020-2031)
Figure 54. Germany Microarray Biochips Revenue (2020-2031) & (US$ Million)
Figure 55. France Microarray Biochips Revenue (2020-2031) & (US$ Million)
Figure 56. U.K. Microarray Biochips Revenue (2020-2031) & (US$ Million)
Figure 57. Italy Microarray Biochips Revenue (2020-2031) & (US$ Million)
Figure 58. Russia Microarray Biochips Revenue (2020-2031) & (US$ Million)
Figure 59. Asia-Pacific Microarray Biochips Sales YoY (2020-2031) & (K Units)
Figure 60. Asia-Pacific Microarray Biochips Revenue YoY (2020-2031) & (US$ Million)
Figure 61. Asia-Pacific Top 8 Manufacturers Microarray Biochips Sales Revenue (US$ Million) in 2024
Figure 62. Asia-Pacific Microarray Biochips Sales Volume (K Units) by Type (2020- 2031)
Figure 63. Asia-Pacific Microarray Biochips Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 64. Asia-Pacific Microarray Biochips Sales Volume (K Units) by Application (2020-2031)
Figure 65. Asia-Pacific Microarray Biochips Sales Revenue (US$ Million) by Application (2020-2031)
Figure 66. Indonesia Microarray Biochips Revenue (2020-2031) & (US$ Million)
Figure 67. Japan Microarray Biochips Revenue (2020-2031) & (US$ Million)
Figure 68. South Korea Microarray Biochips Revenue (2020-2031) & (US$ Million)
Figure 69. China Taiwan Microarray Biochips Revenue (2020-2031) & (US$ Million)
Figure 70. India Microarray Biochips Revenue (2020-2031) & (US$ Million)
Figure 71. Central and South America Microarray Biochips Sales YoY (2020-2031) & (K Units)
Figure 72. Central and South America Microarray Biochips Revenue YoY (2020-2031) & (US$ Million)
Figure 73. Central and South America Top 5 Manufacturers Microarray Biochips Sales Revenue (US$ Million) in 2024
Figure 74. Central and South America Microarray Biochips Sales Volume (K Units) by Type (2021-2031)
Figure 75. Central and South America Microarray Biochips Sales Revenue (US$ Million) by Type (2020-2031)
Figure 76. Central and South America Microarray Biochips Sales Volume (K Units) by Application (2020-2031)
Figure 77. Central and South America Microarray Biochips Sales Revenue (US$ Million) by Application (2020-2031)
Figure 78. Brazil Microarray Biochips Revenue (2020-2025) & (US$ Million)
Figure 79. Argentina Microarray Biochips Revenue (2020-2025) & (US$ Million)
Figure 80. Middle East, and Africa Microarray Biochips Sales YoY (2020-2031) & (K Units)
Figure 81. Middle East and Africa Microarray Biochips Revenue YoY (2020-2031) & (US$ Million)
Figure 82. Middle East and Africa Top 5 Manufacturers Microarray Biochips Sales Revenue (US$ Million) in 2024
Figure 83. Middle East and Africa Microarray Biochips Sales Volume (K Units) by Type (2021-2031)
Figure 84. South America Microarray Biochips Sales Revenue (US$ Million) by Type (2020-2031)
Figure 85. Middle East and Africa Microarray Biochips Sales Volume (K Units) by Application (2020-2031)
Figure 86. Middle East and Africa Microarray Biochips Sales Revenue (US$ Million) by Application (2020-2031)
Figure 87. GCC Countries Microarray Biochips Revenue (2020-2025) & (US$ Million)
Figure 88. Turkey Microarray Biochips Revenue (2020-2025) & (US$ Million)
Figure 89. Egypt Microarray Biochips Revenue (2020-2025) & (US$ Million)
Figure 90. South Africa Microarray Biochips Revenue (2020-2025) & (US$ Million)
Figure 91. Microarray Biochips Industry Chain Mapping
Figure 92. Regional Microarray Biochips Manufacturing Base Distribution (%)
Figure 93. Microarray Biochips Production Process
Figure 94. Regional Microarray Biochips Production Cost Structure
Figure 95. Channels of Distribution (Direct Vs Distribution)
Figure 96. Bottom-up and Top-down Approaches for This Report
Figure 97. Data Triangulation
Figure 98. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
What was the global market size of Microarray Biochips in 2025?
The global market size of Microarray Biochips in 2025 was 1529 Million USD.
What is the annual compound growth rate of the global Microarray Biochips market size from 2025 to 2031?
Which region is expected to have the highest market share?
What was the global market size of Microarray Biochips in 2031?
Which companies rank high in the global Microarray Biochips market?
Related Reports
Global Microarray Biochips Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Microarray Biochips market size was US$ 1529 million in 2025 and is forecast to reach a readjusted size of US$ 2755 million by 2032 with a CAGR of 8.9% during the forecast period 2026-2032.
Published Date: 2026-01-04
Pages: 78
USD 4250.00
(Single User License)
Global Microarray Biochips Market Research Report 2026
The global Microarray Biochips market was valued at US$ 1529 million in 2025 and is anticipated to reach US$ 2755 million by 2032, at a CAGR of 8.9% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 128
USD 2900.00
(Single User License)
Microarray Biochips- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Microarray Biochips was estimated to be worth US$ 1529 million in 2025 and is projected to reach US$ 2755 million, growing at a CAGR of 8.9% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 105
USD 3950.00
(Single User License)
Global Microarray Biochips Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Microarray Biochips market size was US$ 1416 million in 2024 and is forecast to a readjusted size of US$ 2550 million by 2031 with a CAGR of 8.9% during the forecast period 2025-2031.
Published Date: 2025-09-10
Pages: 77
USD 4250.00
(Single User License)
Global Microarray Biochips Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Microarray Biochips was estimated to be worth US$ 1416 million and is forecast to reach approximately US$ 2550 million by 2031 with a CAGR of 8.9% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 123
USD 5900.00
(Single User License)
Microarray Biochips- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Microarray Biochips was estimated to be worth US$ 1416 million in 2024 and is forecast to a readjusted size of US$ 2550 million by 2031 with a CAGR of 8.9% during the forecast period 2025-2031.
Published Date: 2025-01-18
Pages: 96
USD 3950.00
(Single User License)
Global Microarray Biochips Market Research Report 2025
The global market for Microarray Biochips was valued at US$ 1416 million in the year 2024 and is projected to reach a revised size of US$ 2550 million by 2031, growing at a CAGR of 8.9% during the forecast period.
Published Date: 2025-01-18
Pages: 91
USD 2900.00
(Single User License)
Global Microarray Biochips Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Microarray or biochip is a lab-oriented microscope slide that is usually made of glass, silicon chip, or nylon membrane. It is a 2D array (sometimes 3D) whose surface is provided with thousands of minute pores in defined positions. The microarray is a recently developed technology and was discovered only two decades ago. It is mostly used in cancer research and in the pharmacological treatment of other diseases like oral lesions. It enables researchers to investigate and analyze the expression of thousands of genes in a single reaction and address various issues.
Published Date: 2024-04-17
Pages: 151
USD 5600.00
(Single User License)
Global Microarray Biochips Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Microarray or biochip is a lab-oriented microscope slide that is usually made of glass, silicon chip, or nylon membrane. It is a 2D array (sometimes 3D) whose surface is provided with thousands of minute pores in defined positions. The microarray is a recently developed technology and was discovered only two decades ago. It is mostly used in cancer research and in the pharmacological treatment of other diseases like oral lesions. It enables researchers to investigate and analyze the expression of thousands of genes in a single reaction and address various issues.
Published Date: 2024-04-16
Pages: 124
USD 5900.00
(Single User License)
Global Microarray Biochips Market Insights, Forecast to 2030
Microarray or biochip is a lab-oriented microscope slide that is usually made of glass, silicon chip, or nylon membrane. It is a 2D array (sometimes 3D) whose surface is provided with thousands of minute pores in defined positions. The microarray is a recently developed technology and was discovered only two decades ago. It is mostly used in cancer research and in the pharmacological treatment of other diseases like oral lesions. It enables researchers to investigate and analyze the expression of thousands of genes in a single reaction and address various issues.
Published Date: 2024-04-07
Pages: 90
USD 4900.00
(Single User License)
Global Microarray Biochips Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Microarray Biochips market size was US$ 1529 million in 2025 and is forecast to reach a readjusted size of US$ 2755 million by 2032 with a CAGR of 8.9% during the forecast period 2026-2032.
Published: 2026-01-04
Pages: 78
USD 4250.00 (Single User License)Global Microarray Biochips Market Research Report 2026
The global Microarray Biochips market was valued at US$ 1529 million in 2025 and is anticipated to reach US$ 2755 million by 2032, at a CAGR of 8.9% from 2026 to 2032.
Published: 2026-01-04
Pages: 128
USD 2900.00 (Single User License)Microarray Biochips- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Microarray Biochips was estimated to be worth US$ 1529 million in 2025 and is projected to reach US$ 2755 million, growing at a CAGR of 8.9% from 2026 to 2032.
Published: 2026-01-04
Pages: 105
USD 3950.00 (Single User License)Global Microarray Biochips Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Microarray Biochips market size was US$ 1416 million in 2024 and is forecast to a readjusted size of US$ 2550 million by 2031 with a CAGR of 8.9% during the forecast period 2025-2031.
Published: 2025-09-10
Pages: 77
USD 4250.00 (Single User License)Global Microarray Biochips Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Microarray Biochips was estimated to be worth US$ 1416 million and is forecast to reach approximately US$ 2550 million by 2031 with a CAGR of 8.9% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 123
USD 5900.00 (Single User License)Microarray Biochips- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Microarray Biochips was estimated to be worth US$ 1416 million in 2024 and is forecast to a readjusted size of US$ 2550 million by 2031 with a CAGR of 8.9% during the forecast period 2025-2031.
Published: 2025-01-18
Pages: 96
USD 3950.00 (Single User License)Global Microarray Biochips Market Research Report 2025
The global market for Microarray Biochips was valued at US$ 1416 million in the year 2024 and is projected to reach a revised size of US$ 2550 million by 2031, growing at a CAGR of 8.9% during the forecast period.
Published: 2025-01-18
Pages: 91
USD 2900.00 (Single User License)Global Microarray Biochips Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Microarray or biochip is a lab-oriented microscope slide that is usually made of glass, silicon chip, or nylon membrane. It is a 2D array (sometimes 3D) whose surface is provided with thousands of minute pores in defined positions. The microarray is a recently developed technology and was discovered only two decades ago. It is mostly used in cancer research and in the pharmacological treatment of other diseases like oral lesions. It enables researchers to investigate and analyze the expression of thousands of genes in a single reaction and address various issues.
Published: 2024-04-17
Pages: 151
USD 5600.00 (Single User License)Global Microarray Biochips Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Microarray or biochip is a lab-oriented microscope slide that is usually made of glass, silicon chip, or nylon membrane. It is a 2D array (sometimes 3D) whose surface is provided with thousands of minute pores in defined positions. The microarray is a recently developed technology and was discovered only two decades ago. It is mostly used in cancer research and in the pharmacological treatment of other diseases like oral lesions. It enables researchers to investigate and analyze the expression of thousands of genes in a single reaction and address various issues.
Published: 2024-04-16
Pages: 124
USD 5900.00 (Single User License)Global Microarray Biochips Market Insights, Forecast to 2030
Microarray or biochip is a lab-oriented microscope slide that is usually made of glass, silicon chip, or nylon membrane. It is a 2D array (sometimes 3D) whose surface is provided with thousands of minute pores in defined positions. The microarray is a recently developed technology and was discovered only two decades ago. It is mostly used in cancer research and in the pharmacological treatment of other diseases like oral lesions. It enables researchers to investigate and analyze the expression of thousands of genes in a single reaction and address various issues.
Published: 2024-04-07
Pages: 90
USD 4900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now